ECSP078066A - Composiciones y metodos para el tratamiento de síntomas relacionados al ciclo - Google Patents

Composiciones y metodos para el tratamiento de síntomas relacionados al ciclo

Info

Publication number
ECSP078066A
ECSP078066A EC2007008066A ECSP078066A ECSP078066A EC SP078066 A ECSP078066 A EC SP078066A EC 2007008066 A EC2007008066 A EC 2007008066A EC SP078066 A ECSP078066 A EC SP078066A EC SP078066 A ECSP078066 A EC SP078066A
Authority
EC
Ecuador
Prior art keywords
cycle
methods
compositions
treatment
symptoms related
Prior art date
Application number
EC2007008066A
Other languages
English (en)
Inventor
Gary Grubb
Ginger Dale Constantine
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP078066A publication Critical patent/ECSP078066A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proveen métodos para tratar un sujeto femenino con síntomas relacionados con el ciclo, que comprenden la administración de una cantidad efectiva de al menos una progestina y al menos un estrógeno a dicho sujeto femenino, donde tal cantidad efectiva se administra diariamente por al menos 100 días.
EC2007008066A 2005-06-28 2007-12-28 Composiciones y metodos para el tratamiento de síntomas relacionados al ciclo ECSP078066A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69507705P 2005-06-28 2005-06-28

Publications (1)

Publication Number Publication Date
ECSP078066A true ECSP078066A (es) 2008-01-23

Family

ID=37440889

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007008066A ECSP078066A (es) 2005-06-28 2007-12-28 Composiciones y metodos para el tratamiento de síntomas relacionados al ciclo

Country Status (19)

Country Link
US (1) US20070009594A1 (es)
EP (1) EP1896037A2 (es)
JP (1) JP2008544989A (es)
KR (1) KR20080017061A (es)
CN (1) CN101252937A (es)
AR (1) AR054525A1 (es)
AU (1) AU2006263542A1 (es)
BR (1) BRPI0613021A2 (es)
CA (1) CA2612885A1 (es)
CR (1) CR9601A (es)
EC (1) ECSP078066A (es)
GT (1) GT200600280A (es)
IL (1) IL188237A0 (es)
MX (1) MX2007016364A (es)
NO (1) NO20080024L (es)
PE (1) PE20070327A1 (es)
RU (1) RU2007148080A (es)
TW (1) TW200726473A (es)
WO (1) WO2007002862A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
DE102007011486A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Arzneimittel umfassend wenigstens ein Gestagen
CN102665683A (zh) * 2009-10-12 2012-09-12 丽卡实验有限公司 紧急避孕药
UY33103A (es) * 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
WO2012129812A1 (zh) * 2011-03-31 2012-10-04 深圳市康泰尔电子有限公司 电子香烟
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013078422A2 (en) 2011-11-23 2013-05-30 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
DE102019115343A1 (de) * 2019-06-06 2020-12-10 EVESTRA GmbH Vaginalring für die hormonelle Kontrazeption

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
DE19705229C2 (de) * 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1453521B1 (en) * 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
BRPI0412493A (pt) * 2003-07-16 2006-10-17 Duramed Pharmaceuticals Inc métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio
MXPA06013418A (es) * 2004-05-26 2007-01-23 Wyeth Corp Composiciones y metodos para el tratamiento del trastorno disforico premenstrual.

Also Published As

Publication number Publication date
BRPI0613021A2 (pt) 2010-12-14
MX2007016364A (es) 2008-03-05
CA2612885A1 (en) 2007-01-04
NO20080024L (no) 2008-03-27
GT200600280A (es) 2007-02-26
KR20080017061A (ko) 2008-02-25
CR9601A (es) 2008-05-05
PE20070327A1 (es) 2007-05-04
AR054525A1 (es) 2007-06-27
RU2007148080A (ru) 2009-08-10
IL188237A0 (en) 2008-06-05
JP2008544989A (ja) 2008-12-11
EP1896037A2 (en) 2008-03-12
US20070009594A1 (en) 2007-01-11
WO2007002862A3 (en) 2007-02-22
AU2006263542A1 (en) 2007-01-04
TW200726473A (en) 2007-07-16
CN101252937A (zh) 2008-08-27
WO2007002862A2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
ECSP078066A (es) Composiciones y metodos para el tratamiento de síntomas relacionados al ciclo
CR11723A (es) Agente para tratar enfermedad
CO6331301A2 (es) Combinaciones y metodos para administracion subcutanea de inmunoglobulina y hialuronidasa
DOP2006000057A (es) Composición farmaceútica para el tratamiento del cáncer
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
PE20141906A1 (es) Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
CO6341574A2 (es) Composiciones de antagonistas dl pd-1 y metodos de uso
EP2512479A4 (en) METHOD AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE
AR067903A1 (es) Metodo para tratar la depresion mediada por estres
BR112012013847A2 (pt) novos derivados de indolinona ciclopropano
EA200602049A1 (ru) Пролекарства стероидов с андрогенным действием
CO6400226A2 (es) Micrólido anti-inflamatorio
TW200612962A (en) Estriol and estetrol prodrugs
PE20130308A1 (es) Metodos para tratar infecciones bacterianas recurrentes
ECSP066836A (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
NI201200196A (es) Agentes terapéuticos 976
PA8655401A1 (es) Nueva composicion farmaceutica que contiene por lo menos un derivado de dolastatina-10
WO2007123868A3 (en) Organic thiophosphate antiretroviral agents
UY32360A (es) Compuestos de etanamina y métodos de utilización de los mismos 545
AR068608A1 (es) Neramexano para el tratamiento de nistagmo
ECSP088893A (es) 2-alcoxi-3, 4,5-trihidroxi-alquilamida-benzazepinas, su preparación, composiciones que las contienen y utilización
AR065632A1 (es) Una composicion suavizante de tisu
WO2009075838A3 (en) Treatment of menorrhagia with aromatase inhibitor
AR063530A1 (es) Procedimiento de utilizacion de enoxaparina sodica para la preparacion de un medicamento
BR112012006027A2 (pt) composições e métodos para tratar distúrbios de motilidade gastrointestinal.